The Anti-NMDA Receptor Encephalitis Foundation Newsletter

 

Abstract Objective Numerous predictive scores have been developed to help determine which patients with epilepsy or seizures of unknown etiology should undergo neural antibody testing. However, the…

 




Rachael Muggleton was a pre-med student at Penn State when a dangerous brain inflammation called autoimmune encephalitis suddenly struck. Her 6-month stay at Strong Memorial Hospital and the Neuromedicine-ICU team that was with her throughout are shaping this young woman’s future plans.

 




The recognition of seizures secondary to AE represents a rare chance for aetiology-driven seizures management. Early recognition and treatment at the pathogenic level may reduce the risk of long-term irreversible sequelae.

 







Background: Information on the clinical characteristics and severity of autoimmune encephalitis with antibodies against the N-methyl-d-aspartate receptor (NMDAR) in children is attracting more and …

 




Autoimmune encephalitis represents a potentially treatable immune-mediated condition that is being more frequently recognized. Prompt immunotherapy is a key factor for the management of autoimmune encephalitis.

 







Our study supports the notion of a neurobehavioral phenotype of ANMDARE characterized by a fluctuating course with psychotic and affective symptoms, catatonic signs, and global cognitive dysfunction, often accompanied by seizures and dyskinesia.

 




Your donations enable our work. Please consider contributing today. https://www.antinmdafoundation.org/donate/